SEARCH · Search PubMed

Results for “PD”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources

PubMed1995

In vitro biocompatibility, mechanical properties, and corrosion resistance of Ti-Zr-Nb-Ta-Pd and Ti-Sn-Nb-Ta-Pd alloys.

There is much discussion about the toxic effect of vanadium and aluminum contained in Ti-6Al-4V alloy for prosthetic implants. The goal of the present investigation was to develop new titanium alloys with sufficient mechanical properties using more biocompatible alloying elements: zirconium, tin, niobium, tantalum, and palladium. The relative growth rates of L929 and MC3T3-E1 cells were significantly higher when cultured with the extraction of Ti-10Zr-8Nb-2Ta-0.2Pd or Ti-15Zr-4Nb-2Ta-0.2Pd alloys than when cultured with the extraction of Ti-6Al-4AV ELI alloy. The tensile strength, elongation, and reduction of area for Ti-15Sn-4Nb-2Ta-0.2Pd alloy were 989 MPa, 14.4%, and 49.3%, respectively, surpassing Ti-6Al-4V ELI alloy. (ASTM F138-84); those for Ti-15Zr-4Nb-2Ta-0.2Pd alloy were 725 MPa, 23.6% and 54.9%, respectively. More than 15% addition of tin as well as zirconium deteriorated the tensile properties. Titanium release into a 5% hydrochloric acid solution from the new titanium alloys was 20-50 micrograms/cm2 per day, though that from Ti-6Al-4V ELI alloy was 1300 micrograms/cm2 per day. The optimum alloy compositions are Ti-15Zr-4Nb-2Ta-0.2Pd and Ti-15Sn-4Nb-2Ta-0.2Pd, judging from cytocompatibility, corrosion resistance, and mechanical properties. The former is characterized by its higher level cytocompatibility and corrosion resistance, while the latter is characterized by mechanical properties.

Alloys↗

PubMed2004

An infinite zigzag chain of alternating Cl-Pd-Pd-Cl and Mo-Mo units.

Treatment of Pd(2)Cl(2)(CNC(6)H(3)Me(2)-2,6)(4) (1) with Mo(2)(O(2)CCF(3))(4) (2) in dichloromethane afforded an infinite zigzag chain [[Pd(2)Cl(2)(CNC(6)H(3)Me(2)-2,6)(4)][Mo(2)(O(2)CCF(3))(4)]](n) (3), where two metal-metal bonded dinuclear Pd-Pd and Mo-Mo units were bridged by chloro atoms. The Mo-Mo distance (2.1312(3) A) of 3 is significantly elongated compared to that of 2 (2.090(4) A) and lies in the range of that of the quadruple Mo-Mo bonded complexes. Such elongation might be attributed to the axial donation of the chloro atoms of the Pd-Pd unit to the Mo-Mo moiety.

Journal Article↗

PubMed1997

Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.

The dopamine (DA) D3 receptor antagonist PD 58491 [3-[4-[1-[4-[2-[4-(3-diethylaminopropoxy)phenyl]benzoimidazol++ +-1-yl-butyl]-1H-benzoimidazol-2-yl]phenoxy]propyl]diethylamine] bound with high affinity and selectivity to recombinant human DA D3 versus D2L and D4.2 receptors transfected into Chinese hamster ovary cells: Ki values of 19.5 nM versus 2,362 and >3,000 nM, respectively. In contrast, the putative DA D3 receptor antagonist (+)-AJ76 displayed low affinity and selectivity for D3 versus D2L and D4.2 receptors (91 nM vs. 253 and 193 nM, respectively). In vitro, PD 58491 (1 nM-1 microM) exhibited D3 receptor antagonist activity, reversing the quinpirole (10 nM)-induced stimulation of [3H]thymidine uptake in D3 CHOpro-5 cells, but did not have any significant intrinsic activity by itself in this assay. PD 58491 did not decrease the gamma-butyrolactone-induced increase in DA synthesis (L-3,4-dihydroxyphenylalanine accumulation) in rat striatum, indicating that the compound possessed no in vivo DA D2/D3 receptor agonist action at DA autoreceptors. PD 58491 (3-30 mg/kg, i.p.) generally did not alter DA or serotonin synthesis in either the striatum or mesolimbic region of rat brain. The D3-preferring agonist PD 128907 decreased DA synthesis in striatum and mesolimbic regions, and this effect was attenuated by pretreatment with PD 58491. These findings support the hypothesis that DA D3 autoreceptors may in part modulate the synthesis and release of DA in striatum and mesolimbic regions.

5-Hydroxytryptophan↗

PubMed1992

Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.

Plaque formation and dye uptake assays were used to measure the MICs of PD 127,391 and PD 131,628 against Rickettsia species. The MICs of PD 127,391 were 0.25 microgram/ml for Rickettsia rickettsii and 0.125 to 0.25 microgram/ml for Rickettsia conorii. The MICs of PD 131,628 were 0.25 to 0.5 microgram/ml for R. rickettsii and 0.5 microgram/ml for R. conorii. As determined by the shell vial technique, 15 strains of Coxiella burnetii were susceptible to PD 127,391 and PD 131,628 (MIC, < or = 1 microgram/ml), while one strain of C. burnetii (MP10) was of intermediate susceptibility.

Anti-Infective Agents↗

PubMed1987

Bacterial DNA reactivity of the novel antitumor antibiotics PD 114,759 and PD 115,028 (veractamycins A and B).

The novel antitumor antibiotics PD 114,759 and PD 115,028 were evaluated for their ability to cause repairable DNA damage and the induction of SOS functions in bacterial systems. PD 114,759 and PD 115,028 were preferentially toxic to DNA repair-defective Escherichia coli WP100 uvrA recA in comparison to wild-type E. coli WP2 at concentrations of 10 approximately 30 micrograms/ml in agar diffusion assays. Both compounds were inducers of cell filamentation and prophage lambda (two E. coli SOS functions) at concentrations of 0.1 approximately 1 microgram/ml. In addition, the ability of PD 114,759 and PD 115,028 to retain their filamentation-inducing effects under both aerobic conditions and anaerobic conditions suggests that a bioreductive, rather than an oxygen-requiring, mechanism is involved in the DNA-reactive effects of these agents.

Antibiotics, Antineoplastic↗

PubMed1992

[Study of the structure of the duplex (Phn-NH(CH2)2NH)pd(CCAAACA) .pd(TGTTTGGC) with covalently bound 10-(2-hydroxyethyl)phenazine in an aqueous solution by 2D-1H-NMR spectroscopy].

The spatial structure of duplex (Phn-NH(CH2)2NH)pd(CCAAACA).pd(TGTTTGGC) having a N-(2-oxyethyl)-phenazinium residue covalently linked with the 5'-terminal phosphate of the heptanucleotide was studied by means of one- and two-dimensional 1H-NMR spectroscopy. The resonances of phenazinium protons, ethylenediamine linker protons, as well as, oligonucleotide H5/H6/H8/CH3 base protons and H1',H2'a, H2'b, H3', H4' deoxyribose protons have been assigned by means of 1H-COSY, 1H-NOESY and 1H-13C-COSY. The presence of the phenazine residue in duplex causes an additional imino proton signal of the terminal (G-7).(C-1) base pair, suggesting a higher stability of the duplex (Phn-NH(CH2)2NH)pd(CCAAACA).pd(TGTTTGGC) as compared to the unmodified duplex pd(CCAAACA).pd(TGTTTGGC). Analysis of NOE interactions between protons of the dye and the oligonucleotides show the phenazinium polycyclic system to intercalate between G-7 and C-8 residues of the octanucleotide.

Indicators and Reagents↗

PubMed1985

Leucocyte glucose-6-phosphate dehydrogenase (G-6-PD) activity in G-6-PD deficient Chinese.

The activity of glucose-6-phosphate dehydrogenase (G-6-PD) in leucocytes was studied for erythrocyte G-6-PD deficiency using 49 hemizygous males, 16 heterozygous females, and 19 normal controls. The mean G-6-PD activity in leucocytes of the affected neonates (9.2 +/- 5.4 units) and the children (11.2 +/- 5.3 units) were significantly lower than those of normal newborns (22.9 +/- 5.1 units, P less than 0.01). Seventy percent of the effected newborns and 58% of the children with G-6-PD deficiency had the leucocyte enzyme activity of less than 13 IU/10(9)WBC. The leucocyte enzyme activity (14.6 +/- 8.6 units) of 16 heterozygous G-6-PD deficient mothers was also lower than that of normal controls (23.1 +/- 7.0 units). The present study thus concludes that, in G-6-PD deficient Chinese, the enzyme defect is demonstrable not only in erythrocytes but also in leucocytes.

China↗

PubMed1986

G-6-PD Walter Reed: possible insight into "structural" NADP in G-6-PD.

A new G-6-PD variant, G-6-PD Walter Reed, causing hereditary nonspherocytic hemolytic anemia is characterized. This variant is unusual in that its stability requires the presence of high concentrations of NADP, while its Km for NADP is normal. This finding is consistent with the suggestion that G-6-PD has two separate binding sites, a high affinity "structural" site and a lower affinity catalytic site. The mutation in G-6-PD Walter Reed, like that of the previously described variant, G-6-PD Torrance, may be due to a mutation of the "structural" site for NADP.

Anemia, Hemolytic, Congenital↗

PubMed1990

Corrosion behavior of Pd-Cu and Pd-Co alloys in synthetic saliva.

Pd-based alloys are major alternatives to gold-based alloys for PFM applications. In electrolytes simulating oral fluids, these alloys exhibit electrode behavior similar to passivity of active metals, i.e., a potential region of almost constant current density up to a critical potential, above which the current increases. The objective of this study was to correlate the electrode behavior with the results of solution analyses and changes in the surface composition of the alloys. Binary alloys Pd-15 wt% Cu and Pd-19 wt% Co, as well as the pure components, were examined. Corrosion potentials vs. time, potentiodynamic anodic polarization curves, polarization resistances vs. time, and potentiostatic anodic charges were measured with synthetic saliva used as the electrolyte. The concentrations of Pd, Cu, and Co in the solution after various exposures were determined by atomic absorption. The surfaces of the alloys were examined by x-ray photoelectron spectroscopy before and after the exposures. The results show that selective dissolution of the less-noble components occurred on the surfaces of both alloys for all the exposures, leaving the surfaces highly enriched in Pd. This enrichment contributed to the potential changes and the passive-type behavior. Copper dissolved more than cobalt at longer exposures and higher potentials, in spite of its higher nobility. Dissolution of cobalt seemed to be limited by the formation of a surface film, which may be related to the transition character of this element.

Cobalt↗

PubMed2002

Architectural formation of a conjugated bimetallic Pd(II) complex via oxidative complexation and a tetracyclic Pd(II) complex via self-assembling complexation.

The conjugated homobimetallic palladium(II) complex [(L1)Pd(qd)Pd(L1)] (qd = quinonediimine) was obtained in a one-pot reaction by the in-situ oxidative complexation of 1,4-phenylenediamine with the palladium(II) complex [(L1)Pd(MeCN)] (H2L1 = N,N'-bis(2-phenylethyl)-2,6-pyridinedicarboxamide) while in the absence of an additional ligand [(L1)Pd(MeCN)] was converted to the amide-bridged macrocyclic tetramer [Pd(L1)]4.

Journal Article↗

PubMed2004

Reactivity of an anionic Pd(II) metallacycle with CH2X2 (X=Cl, Br, I): formal insertion of methylene into a Pd-C(aryl) bond.

Whereas the reaction of the anionic palladium metallacycle [K[Pd(CH2CMe2-o-C6H4)(kappa2-Tp)]] with CH2Cl2 leads to the isolation of the stable Pd(IV) chloromethyl complex [Pd(CH2CMe2-o-C6H4)(kappa3-Tp)(CH2Cl)], the analogous reactions with CH2Br2 and CH2I2 give rise to the six membered metallacycles [Pd(CH2CMe2-o-C6H4(CH2))(kappa3-Tp)X](X = Br or I), as a result of the formal insertion of CH2 into the Pd-C(aryl) bond.

Journal Article↗

PubMed2006

Palladium complexes with Pd-->B dative bonds: analysis of the bonding in the palladaboratrane compound [kappa4-B(mimBut)3]Pd(PMe3).

The dinuclear complex {[mu-kappa(1),kappa(3)-B(mim(Bu(t)))(3)]Pd}(2), which features a Pd-->B dative bond, may be obtained by the reaction of [Tm(Bu(t))]K with Pd(OAc)(2); treatment of {[mu-kappa(1),kappa(3)-B(mim(Bu(t)))(3)]Pd}(2) with PMe(3) affords the mononuclear boratrane derivative [kappa(4)-B(mim(Bu(t)))(3)]Pd(PMe(3)), for which a molecular orbital analysis indicates that the palladium center possesses a d(8) configuration.

Journal Article↗

PubMed2001

Development of Ag-Pd-Au-Cu alloys for multiple dental applications. Part 2. Mechanical properties of experimental Ag-Pd-Au-Cu alloys containing Sn or Ga for ceramic-metal restorations.

Eighteen Ag-Pd-Au-Cu alloys, consisting of nine Ag-Pd-Au-Cu mother compositions (Pd: 20, 30 or 40%, Au: 20%, Cu: 10, 15 or 20%, Ag: balance) containing either 5% Sn or 5% Ga as an additive metal, were experimentally prepared. Tensile strength, proof stress, elongation, elastic modulus, and Vickers hardness of these alloys were evaluated to clarify the potential of these alloys for use as ceramic-metal restorations as well as the effects of the Pd and Cu contents on their mechanical properties. The tensile strength, proof stress, elongation, elastic modulus and Vickers hardness of the 18 experimental alloys were in the range of 410.0-984.0 MPa, 289.7-774.3 MPa, 2.2-23.7%, 81.3-123.0 GPa and 135.7-332.3 HV1, respectively. Ten of the 18 experimental alloys can be used for ultra-low fusing ceramics based on their proof stress, elastic modulus, elongation and hardness. Between the Ga- and Sn-added alloys, differences in tensile strength, proof stress, elongation and hardness were found at several Ag-Pd-Au-Cu compositions.

Analysis of Variance↗

PubMed1986

Antimycotic effects of the novel antitumor agents fostriecin (CI-920), PD 113,270 and PD 113,271.

The novel fermentation products fostriecin and analogs PD 113,270 and PD 113,271 are structurally related polyene lactone phosphates that have antitumor activity in vitro and in vivo. They have no antibacterial effects, but they were inhibitory to yeasts (agar diffusion method) with MICs of 3 approximately 300 micrograms/ml. Fostriecin or its analogs were active vs. 29 of 46 yeast species (11 genera). Ten of 12 cultures of Candida sp. were not sensitive to any of the analogs, while 11 of 14 cultures of Saccharomyces sp. were inhibited by one or more of the agents. Sensitivity patterns were of three types: Twelve cultures were sensitive only to PD 113,270; fostriecin and PD 113,271 (but not PD 113,270) were active vs. 7 cultures; and 9 cultures were sensitive to all three compounds. Dephosphorylation of the compounds resulted in the loss of antimycotic effects. Activity vs. the yeasts was related to studies of uptake and activity against cancer cells.

Alkenes↗

PubMed1980

Leucocyte glucose-6-phosphate dehydrogenase (g-6-pd) activity in g-6-pd deficient subjects.

The activity of glucose-6-phosphate dehydrogenase (G-6-PD) in leucocytes was studied in the following group of Greek people. Group 1: 43 male children and 16 male students with mean values of enzyme activity of 27.7 +/- 16.6 units and 24.6 +/- 5.6 units, respectively. Group 2: 15 G-6-PD deficient male children who had never experienced an acute haemolytic episode with a mean value of 10.8 +/- 4.6 units. Group 3: 19 G-6-PD deficient male children during favism and 3 months after the haemolytic crisis with mean values of 8 +/- 4 units and 9.2 +/- 1.9 units, respectively. Group 4: 19 mothers of children from group 3 who by definition were carriers of G-6-PD deficiency had a mean value of 18.2 +/- 8.2 units. The difference between means for group 1 and groups 2, 3 and 4 is highly significant (P < 0.001). Therefore the enzymatic defect in Greek people is not limited to the erythrocytes but can be also demonstrated in leucocytes.

Adult↗

PubMed2024

Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor.

The gut microbiome significantly influences immune responses and the efficacy of immune checkpoint inhibitors. We conducted a clinical trial (NCT04264975) combining an anti-programmed death-1 (PD-1) inhibitor with fecal microbiota transplantation (FMT) from anti-PD-1 responder in 13 patients with anti-PD-1-refractory advanced solid cancers. FMT induced sustained microbiota changes and clinical benefits in 6 of 13 patients, with 1 partial response and 5 stable diseases, achieving an objective response rate of 7.7% and a disease control rate of 46.2%. The clinical response correlates with increased cytotoxic T cells and immune cytokines in blood and tumors. We isolated Prevotella merdae Immunoactis from a responder to FMT, which stimulates T cell activity and suppresses tumor growth in mice by enhancing cytotoxic T cell infiltration. Additionally, we found Lactobacillus salivarius and Bacteroides plebeius may inhibit anti-tumor immunity. Our findings suggest that FMT with beneficial microbiota can overcome resistance to anti-PD-1 inhibitors in advanced solid cancers, especially gastrointestinal cancers.

Adult↗

PubMed2000

Anionic Pd(0) and Pd(II) intermediates in palladium-catalyzed Heck and cross-coupling reactions.

The anions of PdCl(2)L(2) and Pd(OAc)(2), precursors of palladium(0) used in cross-coupling and Heck reactions, play a crucial role in these reactions. Tricoordinated anionic complexes Pd(0)L(2)Cl(-) and Pd(0)L(2)(OAc)(-) are the effective catalysts instead of the usually postulated Pd(0)L(2) complex. The anion ligated to the palladium(0) affects the kinetics of the oxidative addition to ArI as well as the structure and reactivity of the arylpalladium(II) complexes produced in this reaction. Thus, pentacoordinated anionic complexes are formed, ArPdI(Cl)L(2)(-) or ArPdI(OAc)L(2)(-), the precursor of neutral trans-ArPd(OAc)L(2), instead of the usually postulated trans-ArPdIL(2) complex (L = PPh(3)).

Anions↗

PubMed2005

Cyclodiphosphazanes with hemilabile ponytails: synthesis, transition metal chemistry (Ru(II), Rh(I), Pd(II), Pt(II)), and crystal and molecular structures of mononuclear (Pd(II), Rh(I)) and bi- and tetranuclear rhodium(I) complexes.

Cyclodiphosphazanes having hemilabile ponytails such as cis-[(t)()BuNP(OC(6)H(4)OMe-o)](2) (2), cis-[(t)()BuNP(OCH(2)CH(2)OMe)](2) (3), cis-[(t)BuNP(OCH(2)CH(2)SMe)](2) (4), and cis-[(t)BuNP(OCH(2)CH(2)NMe(2))](2) (5) were synthesized by reacting cis-[(t)()BuNPCl](2) (1) with corresponding nucleophiles. The reaction of 2 with [M(COD)Cl(2)] afforded cis-[MCl(2)(2)(2)] derivatives (M = Pd (6), Pt (7)), whereas, with [Pd(NCPh)(2)Cl(2)], trans-[MCl(2)(2)(2)] (8) was obtained. The reaction of 2 with [Pd(PEt(3))Cl(2)](2), [{Ru(eta(6)-p-cymene)Cl(2)](2), and [M(COD)Cl](2) (M = Rh, Ir) afforded mononuclear complexes of Pd(II) (9), Ru(II) (11), Rh(I) (12), and Ir(I) (13) irrespective of the stoichiometry of the reactants and the reaction condition. In the above complexes the cyclodiphosphazane acts as a monodentate ligand. The reaction of 2 with [PdCl(eta(3)-C(3)H(5))](2) afforded binuclear complex [(PdCl(eta(3)-C(3)H(5)))(2){((t)BuNP(OC(6)H(4)OMe-o))(2)-kappaP}] (10). The reaction of ligand 3 with [Rh(CO)(2)Cl](2) in 1:1 ratio in CH(3)CN under reflux condition afforded tetranuclear rhodium(I) metallamacrocycle (14), whereas the ligands 4 and 5 afforded bischelated binuclear complexes 15 and 16, respectively. The crystal structures of 8, 9, 12, 14, and 16 are reported.

Journal Article↗